CD4 and neoplasm: By the way, the infusion of bulk cultures containing up to 98% of CD4+ T cells of undefined specificity was carried out in patients without adverse events, thus indicating that such B cell-specific T cells, if present, likely target an antigen(s) overexpressed by tumor cells (176).